The Irish Times view on the Polish election: a landmark win for the right
There is a sense of déjà vu about
the victory of Trump-endorsed, nationalist right-winger Karol Nawrocki
in Sunday's Polish presidential election. Polish voters had decided last year to replace the conservative and Eurosceptic Law and Justice (PiS) government with a coalition led by Donald Tusk's liberal centrist Civic Union (CU). However, at the weekend they voted by the narrowest of margins – 50.9 per cent to 49.9per cent - in favour of the PiS retaining the presidential office. The outgoing president Andrzej Duda repeatedly used his right to veto much of Tusk's reformist agenda.
A key area has been the reform of the judicial system ,where wholesale manipulation by the former PiS government had seen Poland leading Hungary into a major confrontation with its European allies over their determination to protect the rule of law. Hungary was unsurprisingly the first country to congratulate Nawrocki.
Now, if Nawrocki is successful in blocking EU-required reforms, he may well also undermine Warsaw's attempts to restore billions of withheld EU funding.
In 2020, Duda had won the presidency, defeating Nawrocki's opponent, liberal pro-EU mayor of Warsaw, Rafal Trzaskowski, by a similar margin to the weekend vote. The deep, urban-rural, conservative-liberal divisions that have riven Polish society seem not to have healed an inch, and the PiS views Sunday's election as a harbinger of its return to power in government in 2027.
READ MORE
Now the prospect is for legislative gridlock that will delight not only fellow EU populist parties but seriously undermine Poland's emerging leadership role in the EU. It comes just two weeks after the defeat in Romania of a populist candidate, George Simion, which many over-optimistically felt suggested the ebbing of the tide of populism.
Nawrocki, a historian , amateur boxer and former football hooligan with no political experience, vigorously denied an avalanche of allegations against him during a campaign he fought under a slogan of 'Poland First'. He attacked EU policies on climate change, Ukraine's Nato accession, and promised to torpedo attempts to promote LGBTQ+ rights and more liberal abortion laws. 'We will save Poland, we will not allow the power of Donald Tusk to be complete,' he promised as word of the result came in.
The Polish constitution limits the presidency to largely ceremonial duties. However, the president can obstruct – and holds a veto on legislation which can only be overturned on a now-elusive three-fifths majority vote of parliament.
Poland faces in to a prolonged period of polarised confrontation, unable to move forwards or backwards politically, and one that will certainly hobble the EU's efforts at a critical time. And Nawrocki's victory is telling evidence of the continued resilience of populism and nationalism.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Agriland
2 hours ago
- Agriland
ICOS AGM: ‘Promising' developments amid uncertainty in farming
Despite high levels of uncertainty facing farming, there are 'promising political and market developments' that could support the sector in the year ahead. That's according to Edward Carr, the president of the Irish Co-operative Organisation Society (ICOS), who told the organisation's annual general meeting (AGM) yesterday (Tuesday, June 3): 'Perhaps society is finally recognising that quality food is both difficult and expensive to produce, and it must be paid for accordingly.' The AGM was held in Portlaoise, Co. Laois, in which Carr told stakeholders: 'We live in interesting times'. 'While the term 'unprecedented' is often overused, it rightly describes the challenges currently confronting co-ops and food producers.' Carr welcomed what he said were recent shifts at an EU level, saying that the 2024 European Parliament elections prompted centrist groups to 'rethink recent policies that alienated farmers'. 'The previous [European] Commission's overly purist Green Deal and dismissive attitude towards agriculture played a significant role in driving voters toward the political extremes. 'Now, we see a more balanced approach, with new agriculture and environment commissioners, Christoph Hansen and Jessika Roswall [respectively] showing early signs of being more responsive and pragmatic,' Carr said. However, he added that legal environmental commitments for farming remain in place and 'must be met'. Commenting on market conditions, he said that the prices of milk and meat are at 'unprecedented levels', supported by currently weak global supply. However, these prices are 'countered' by cost bases within the agri-sector that are constantly rising, according to Carr. 'This trend confirms what we've been saying for years. Farming has been pushed into a position where it is unattractive to younger generations. The costs are high, inflation is locked-in, the hours are long and the rewards are limited.' He also warned that global geopolitical risks, including continuing conflict, the trade impact of the current US administration under Donald Trump, and the rise of 'authoritarian voices' in Europe, could threaten stability. 'The European project, and in particular the Single Market, remains vital for Ireland's economic future. We need strong leadership to ensure that Europe continues to work for its citizens, farmers included, not just for ideological visions,' Carr commented. He also told the ICOS AGM that environmental responsibility is important, particularly in relation to the nitrates derogation. 'We've made huge strides in improving water quality, though the time lag between action and results remains frustrating. Still, the perseverance of co-ops, farmers, Teagasc, and the Department of Agriculture is beginning to bear fruit. 'Retaining the derogation is essential, not just for dairying but for the entire agri-sector,' he said. One of key issues for the year ahead, according to Carr, is the future of the Common Agricultural Policy (CAP), amid concerns that its standalone ringfenced budget could be radically overhauled. 'Agriculture and the CAP are under pressure, with serious risk that funds could be diverted to other priorities. This would be deeply damaging, not just to the basic payments scheme [Pillar I], but also to Pillar II, which is critical to delivering sustainability goals. In fact, we don't need two pillars, we need a third,' he said. 'CAP is the foundation of a sustainable and competitive farming and agri-food sector in Ireland and Europe. It plays a vital role in maintaining farm incomes, supporting rural communities and driving progress on climate and environmental goals across the EU. 'What we need is a strong, practical and fully resourced CAP; one that cuts red tape and empowers farmers to focus on producing food, not paperwork. Farming in Ireland and across the EU is struggling to attract young farmers,' Carr added. He called on the European Commission not to risk 'accelerating the generational renewal crisis'. 'Rather than potentially seeking mechanism to undermine and defund CAP, the European Commission must stand by its farming citizens, underpin food security and protect this essential policy,' he said. The ICOS president called on policymakers to 'stand firm in defence of farming', adding: 'Our sector is ready to do its part, but we need the tools and resources to do it'.
Agriland
2 hours ago
- Agriland
DAFM: First round of AMS notifications due later this month
The Department of Agriculture, Food and the Marine (DAFM) has confirmed that the first round of Area Monitoring System (AMS) notifications will be sent to farmers later this month. The AMS is the observation and assessment of agricultural activities and practices on agricultural areas. The system uses Copernicus Sentinel satellite data which is gathered automatically every five days and stored to provide up-to-date information as required. AMS Under the current Common Agricultural Policy (CAP), the AMS is mandatory across all EU member states to monitor compliance with farm scheme criteria. The AMS interprets satellite imagery to provide decisions on agricultural activity on all declared land parcels of which there are approximately 1.1 million in Ireland. The department is monitoring all area-based schemes with data gathered by the system. DAFM spokesperson told Agriland:'The first round of AMS notifications will focus on the presence of potential artificial surfaces and will issue end of June with a deadline for receipt of responses of July 8, 2025.' 'The second round of notifications will issue mid-July and will notify on potential non-compliance detected for incorrect crops, potential ineligible areas, and no evidence of agricultural activity. 'The third round of notifications will issue mid-August and will notify on potential non-compliance detected for incorrect crops, potential ineligible areas, no evidence of agricultural activity and no evidence of ACRES winter bird food. 'The deadline for receipt of completed responses for both rounds 2 and 3 will be 2nd September 2025,' the spokesperson added. DAFM issued over 5,800 notifications to landowners this year due to potential scheme issues being detected through the AMS.
RTÉ News
2 hours ago
- RTÉ News
EU states adopt new controversial medicine regulations
EU member states have adopted a controversial set of new measures governing the regulation of medicines at European level, following two years of deadlock and "unprecedented" lobbying by the pharma sector, particularly in Ireland. The new laws will broadly reform the regulation of medicines and, critically, the issue of when to give generic drug makers access to clinical data, which tends to make certain medicines cheaper. At a meeting of EU ambassadors in Brussels this morning, the so-called pharma package received overwhelming support, with Malta registering a sole abstention. The package will now go forward for negotiation with the European Parliament. Officials say the current upheaval in the United States, where thousands of staff from the Food and Drug Administration (FDA) have been fired, and where the Trump Administration has taken a hostile attitude to science and research, prompted a large number of member states to try to get the legislation over the line. The pharma package had been deadlocked for over two years. A key sticking point has been the length of the clinical data protection period. Under existing rules, pharmaceutical companies have enjoyed an eight-year period during which rival or generic producers cannot access the clinical data related to authorised products. The provision was intended to encourage manufacturers to invest in the EU by having a guaranteed period of sole clinical data ownership. The European Commission's initial proposal was to reduce the eight years to six, on the basis that producers of generic medicines could access the data sooner, and thus produce cheaper alternatives. Under the original proposal, the patent holder could claw back two years by, for example, ensuring that trials were conducted in many member states. Ireland initially leaned in favour of the six year approach but, following intense lobbying by the pharma industry, moved toward the eight year status quo. Last month, Minister for Enterprise Peter Burke acknowledged that Ireland was shifting to the eight year protection period. He told reporters in Brussels: "We really need to have innovation in that sector, because that will give people, ultimately, access to better health care, better medicines, and ensure that we are incentivising innovation and being at the cutting edge of medical developments. "We have to get a balance between access to medicines, which is so important for citizens, but also to keep the pipeline strong so that we are at the cutting edge of innovation, and that companies have certainty as they go about developing new medicines. It is a balancing act." The Polish Presidency of the EU proposed a compromise text which would see the clinical data protection period remain at eight years. There would be a further two years where for one year the pharmaceutical company would get an extra year of market protection and a second year whereby protection would continue if they carry out more trials in member states and if they produced certain kinds of medicines for an "unmet medical need". Officials say the text provides more reassurance for generic producers and will cut timelines for authorised medicines to get to market. There are other measures, including making it easier to have multi-country and multilingual medicine packs, which should reduce production costs and make it easier to move medicines around Europe. It is understood that Ireland regards the compromise as a balance between the need to ensure pharmaceutical companies continue to innovate and invest in European research, while providing access for generic producers and ensuring the production of safe medicines. However, sources acknowledge an "unprecedented" degree of lobbying by the pharma sector, with representations being made to both the Taoiseach's and Tánaiste's offices, as well as to the Department of Health. The legislation has been deeply divisive, with member states falling into opposing camps of those wanting to promote medical research in Europe and those more concerned about cheaper drugs for patients. There are hopes that the final legislation could be adopted by the end of the year.
